跳至主要内容
临床试验/IRCT201205305113N3
IRCT201205305113N3已完成3 期

The effect of N-Acetyle Systeine in preventing contrast induced nephropathy in patients with different stages of chronic kidney diseases

ephrology Research Center, Tehran University of Medical Sciences0 个研究点目标入组 549 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
549

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 99 years(—)
性别
All

入选标准

  • age more than 18; serum creatinine more than 1.5 mg/ dl ; not having AKI; not receiving nephrotoxine since 1 week before entering the study; signing the consent.
  • Exclusion criteria: the patients who undergo surgery in less than 1 week of contrast exposure; the patients who are in need for a nephrotoxine in less than five days after contrast exposure; the patients who need repeated contrast administration in less than five days of first exposure

排除标准

  • 未提供

研究者

发起方
ephrology Research Center, Tehran University of Medical Sciences

相似试验